Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells

Published:2022-07-12 Issue:9 Volume:113 Page:3193-3210
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Ohno Koichi¹,Shibata Tomohiro¹,Ito Ken‐ichi¹^ORCID

Affiliation:

1. Division of Breast and Endocrine Surgery, Department of Surgery Shinshu University School of Medicine Matsumoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15465

Reference53 articles.

1. Understanding the ever-changing incidence of thyroid cancer

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the A rt and New Perspectives with Patents Recently Applied

4. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?

5. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer;International Journal of Clinical Oncology;2024-07-23

2. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning;Frontiers in Endocrinology;2023-12-08

3. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma;Frontiers in Genetics;2023-07-04

4. Challenges and Strategies to Combat Resistance Mechanisms in Thyroid Cancer Therapeutics;Thyroid;2023-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3